Documente Academic
Documente Profesional
Documente Cultură
Andrew B. Kennedy
To cite this article: Andrew B. Kennedy (2018) China's Innovation Trajectories, Survival, 60:3,
71-86, DOI: 10.1080/00396338.2018.1470756
Andrew B. Kennedy is senior lecturer in policy and governance at the Crawford School of Public Policy at the
Australian National University. He is the author of The Conflicted Superpower: America’s Collaboration with China
and India in Global Innovation (Columbia University Press, 2018).
This article suggests that the question must be rethought. Chinese devel-
opment is not following a single path; different parts of the country are on
very different trajectories. Critical features of China’s innovation landscape,
particularly Chinese firms, remain relatively weak. In other respects, China
is developing with remarkable speed. The R&D activity of foreign firms in
China, and the research and international collaboration being carried out by
top Chinese scientists, are impressive in a number of ways.
China’s points of weakness, combined with the increasingly global
nature of innovation, mean that the country will continue to need collabora-
tion with more developed countries in some areas for years to come. China’s
emerging strengths, in turn, make it an increasingly attractive partner
for foreign companies and universities, even as tensions have mounted
between Beijing and foreign technology firms in recent years. At the same
time, China’s changing profile poses important challenges for the outside
world, both military and economic, that the US and its allies must address.
firms derived 19%.7 More generally, China’s share of the world’s top 100
companies (in terms of market capitalisation) remained stuck at 11% from
2009 to 2017, even as the US share rose from 42% to 55%.8
The struggles of Chinese firms are not surprising, given that the Chinese
government often intervenes in the country’s economy and society in
ways that degrade the efficiency of the innovation system. State banks
and government-sponsored initiatives have long privileged state-owned
enterprises, for example, but these are hardly China’s most innovative
firms.9 More recently, the government’s 13th five-year plan included
remarkably detailed technology initiatives, which could conflict with the
investment plans of Chinese companies.10 Various levels of the government
are also heavily involved in the country’s booming venture-capital industry,
creating distortions in the market and sometimes placing conditions
on entrepreneurs.11 In other respects, it is the inactivity of the Chinese
government that is problematic. Weak protection of intellectual property
(IP) poses a particular challenge for would-be innovators in China, who
must contend with competition from a wide array of imitators.12
China does have success stories, of course. The country is well known for
‘efficiency-based’ innovation – improving production processes, product
design and supply-chain management to reduce cost and time to market.13
Some Chinese firms excel at ‘customer-based’ innovation, showing height-
ened sensitivity to customer needs, as evidenced by the country’s rapid
development of financial technology (‘fintech’). And while Chinese firms
are weaker in engineering- and science-based innovation, there are impor-
tant exceptions. Huawei stands out in this regard: a global success story,
the firm not only ranks among the world leaders in terms of total R&D
spending, but also typically devotes a sizeable portion (20–30%) to more
ambitious ‘research and innovation’ projects.14 In addition, some China-
based but foreign-financed ‘hybrid firms’, such as Alibaba, have succeeded
in part because of the discipline imposed by their foreign financing.15 In the
long term, China could conceivably develop leading firms in sectors ranging
from semiconductors to biotech, as envisioned in the ‘Made in China 2025’
plan, though this is hardly guaranteed.16 For now, however, China’s firms
remain a relatively weak link in the country’s innovation system.
74 | Andrew B. Kennedy
Can Chinese firms make up for their weaknesses through illicit means?
Some have certainly tried. But how much Chinese firms can gain from
stolen technology is unclear. Some argue that, as American cyber-security
firm Mandiant put it, ‘stolen information can be used to obvious advan-
tage by the PRC [People’s Republic of China] and Chinese state-owned
enterprises’.17 This has clearly been the case in some instances. Yet recent
scholarship has demonstrated that the challenges of stealing, assimilating
and applying valuable information can be formidable.18 The most valuable
information can be difficult to locate, and crucial knowledge needed to apply
it may not be written down, existing instead in the form of tacit knowledge
or organisational routines.19 Relying on stolen technology also risks creat-
ing organisations that are optimised for imitation rather than innovation.20
The extent and nature of China’s reliance on economic espionage may be
changing as well. There is evidence that the scale of Chinese cyber espio-
nage against private companies has declined in recent years, following
domestic reforms in China, public exposure and actions by the US govern-
ment.21 While China’s activity continues – some have even suggested that it
increased in the second half of 2017 – US officials believe it has become more
targeted and calculating.22 Taking all these points together, it is unclear just
how much economic espionage will benefit Chinese firms going forward.
Foreign R&D
Foreign firms’ R&D investment in China has grown rapidly over the past
two decades. Indeed, according to one estimate, China attracted more than
twice as much new foreign R&D investment (in terms of value) as the United
States from 2010 to 2014.23 In general, US firms have led the way in making
R&D investments in China. From 2005 to 2013, for example, US companies
spent 2.7 times more than Japanese companies did on R&D in China.24
The list of companies making investments includes top information- and
communication-technology firms such as Microsoft and Intel and, more
recently, pharmaceutical giants such as Pfizer and Amgen. Microsoft
has been a particularly noteworthy player. Microsoft Research Asia was
established in Beijing in 1998 and has become the company’s second-largest
research organisation, after its counterpart in the United States. The centre’s
China’s Innovation Trajectories | 75
China has also become far and away the leading source of foreign
collaborators for American scientists. Chinese scientists and engineers
published nearly 44,000 articles with US counterparts in 2016 – a dramatic
increase from just 5,406 in 2003.36 China’s total in 2016 nearly equalled
the figures for the next two leading partners – the United Kingdom and
Germany – put together. Popular fields of collaboration have included
materials science, electrical engineering, biochemistry, chemistry and
multidisciplinary science.
The growing collaboration between American and Chinese scientists
is not surprising. China’s top scientists are often educated overseas, fre-
quently in the United States, or hold post-doctoral fellowships abroad.
Peking University’s chemistry department, for example, includes graduates
of Harvard, MIT, California Institute of Technology, Columbia, Berkeley,
the University of Pennsylvania and the University of Chicago, among
other US universities. Overall, 92% of the department’s faculty had either
received a PhD or held a post-doctoral position abroad as of mid-2016. The
corresponding figure for Tsinghua University’s chemistry department was
77%.37 Moreover, some Chinese scientists are receiving international acclaim
for their laboratories’ accomplishments. In 2015, the London-based Physics
World awarded its ‘Breakthrough of the Year’ award to Pan Jianwei and Lu
Chaoyang at the University of Science and Technology in Anhui for their
work in quantum teleportation. Another Chinese team was among the top
ten contenders for the award.38
Collaboration with foreign scientists is part of the explanation for China’s
increasing prowess in scientific publishing. This is particularly evident in
the top journals. In 2014 and 2015, nearly 80% of the articles published in
Cell featuring a China-based author also featured a US-based one (see Figure
1 below). The figures for Nature and Science were also high. In some of the
less luminary Nature Index journals, however, the rate of co-authorship
between Chinese and US scientists is much lower. In Analytical Chemistry,
for example, the figure is a mere 12%.39
In short, China’s elite scientists, if not the average Chinese researcher,
are gaining in international prominence. This accomplishment is all the
more noteworthy given that the Chinese government has not traditionally
78 | Andrew B. Kennedy
90
80
70
60
50
40
30
20
10
0
Cell Nature Science Journal of Journal of the Analytical
High Energy American Chemistry
Physics Chemical Society
2015 survey found that 91% of Chinese scientists felt that more should be
done to detect, prevent and punish misconduct.46
Even so, serious efforts to address some of these problems are being made.
The last few years have seen the government overhaul the research-funding
system, which has included the elimination of long-standing programmes
and the consolidation of funding into five major streams. The government is
also setting up a range of professional scientific associations (zhuanye jigou)
to administer these streams and improve project management. The massive
Chinese Academy of Sciences is undergoing a range of reforms, and new
national laboratories are being established to promote interdisciplinary
research. Top institutions are also experimenting with more nuanced and
flexible means of performance evaluation. These reforms are still a work in
progress, and it remains to be seen just how successful they will be, but it is
clear that Chinese science is not standing still.47
For all its problems, then, basic scientific research is developing in a more
impressive fashion than is Chinese corporate R&D. Top Chinese scientists
are well connected abroad and collaborate frequently with counterparts in
more developed countries. They can also point to a rapidly growing list of
accomplishments, even though funding for basic science has not been the
Chinese government’s priority. Although many problems remain, there are
also concerted efforts being made to address them.
foreign counterparts, saying, ‘Even if you localize, make your own CPUs
[central processing units], make your own operating systems, make your
own database software, it would still be at a grade school level [with] your
[security measures] transparent to … college students’.48
The downside of China’s weakness in this regard is that the country’s
efforts to acquire foreign technology through unwelcome channels will
continue. Pressure on foreign firms to transfer technology to local partners,
for example, will likely persist in one form or another. While economic
espionage may have abated in some areas, it is difficult to monitor, and it
is apparent that some efforts continue. China’s fear of foreign technologi-
cal domination will also mean that the government will continue to worry
about foreign firms’ market share in the country. The danger for China is
that these tendencies will alienate other governments that are economic
partners (as is already happening with the United States), or that foreign
firms will become less interested in the country as an R&D platform.
Secondly, China’s emerging strengths represent important opportu-
nities for innovators in more developed countries. Sophisticated foreign
R&D centres help facilitate access to China’s varied and changing market
through what China analyst Nick Marro has called the ‘in China, for China’
approach.49 They also allow foreign firms to tap China’s talented and
growing supply of human capital for more globally oriented projects, at least
when IP concerns do not deter such collaboration. China’s top universities
are generating knowledge and collaborators for scientists and engineers in
other countries. They are also emerging as partners for foreign companies
in recruiting, research and branding. And while many Chinese firms are
still lagging, there are also cases where collaboration between Chinese and
foreign firms has been productive.
Yet China’s rising profile also poses a range of serious challenges for
developed countries. Firstly, China’s growing capacity for innovation has
implications for the country’s military power. In recent years, China’s
leaders have pursued ‘military–civil fusion’ (junmin ronghe) in an intensi-
fied effort to leverage both military and civilian resources as they modernise
the country’s armed forces.50 As part of this effort, China’s military now
works more closely with the country’s universities and civilian firms invest-
China’s Innovation Trajectories | 81
* * *
Acknowledgements
The author would like to thank Tai Ming Cheung for feedback on an earlier version of
this article. He also wishes to thank Rongfang Pan and Nan Liu for excellent research
assistance. The standard caveats apply.
Notes
1 ‘China’s Spending on R&D Jumps (Washington DC: Center for Strategic
14pc in 2017 to US$279 Billion’, South and International Studies, 2017), p. 39.
China Morning Post, 27 February 2018, 5 ‘High Quantity, Low Quality: China’s
23, no. 2, 2016, pp. 71–2. Zhongguo Keji Tongji Nianjian 2016
4 Scott Kennedy, The Fat Tech Dragon: [China Statistical Yearbook on Science
Benchmarking China’s Innovation Drive and Technology 2016] (Beijing:
84 | Andrew B. Kennedy
507, no. 7,491, 13 March 2014, pp. Science in 2017’, Scientific American,
148–9; ‘Fraud in Academia Is Killing 14 December 2017, https://www.
China’s Nobel Dream’, South China scientificamerican.com/article/
Morning Post, 10 February 2014, how-trump-shaped-science-in-2017/.
http://www.scmp.com/comment/ 53 Ryan Singel, ‘If the FCC Kills Net
17 December 2015, pp. S170–73; and They Are Being Choked by New Visa
Cong Cao and Richard P. Suttmeier, Rules’, Business Insider, 30 November
‘Challenges of S&T System Reform 2017, https://www.businessinsider.
in China’, Science, vol. 355, no. 6,329, com.au/australia-startups-457-visa-
2017, pp. 1,019–21. rules-2017-11.
48 Quoted in Gerry Shih, ‘Exclusive: 56 Kennedy, The Conflicted Superpower,